Condition: Cirrhosis, Liver · Hepatorenal Syndrome · Acute Kidney Injury · Sponsor: Jena University Hospital
The study compares the effectiveness and safety of TIPS implantation in patients with HRS-AKI (stage1, 2 and 3) and liver cirrhosis with standard therapy (drug therapy with terlipressin + albumin).
This description comes directly from the study's public registry record.
Cristina Ripoll, Prof. Dr. · +4936419 · cristina.ripoll@med.uni-jena.de
Alexander Zipprich, Prof. Dr. · +4936419 · alexander.zipprich@med.uni-jena.de
Always discuss trial participation with your own doctor first.
| University Hospital RWTH Aachen | Aachen, Germany | Recruiting |
| Charité - Universitätsmedizin Berlin CVK | Berlin, Germany | Not Yet Recruiting |
| University Hospital Dresden, Medical Clinic I, Gastroenterology | Dresden, Germany | Recruiting |
| Universitätsklinikum Essen (AöR) | Essen, Germany | Not Yet Recruiting |
| University Hospital Freiburg | Freiburg im Breisgau, Germany | Recruiting |
| University Hospital Halle | Halle, Germany | Recruiting |
| University Hospital Hamburg-Eppendorf | Hamburg, Germany | Recruiting |
| Medical University Hannover | Hanover, Germany | Recruiting |
| Jena University Hospital, Clinic for Inner Medicine IV | Jena, Germany | Recruiting |
| Klinikum Landshut AdöR der Stadt Landshut | Landshut, Germany | Not Yet Recruiting |
| University Hospital Leipzig | Leipzig, Germany | Not Yet Recruiting |
| RKH Clinic Ludwigsburg | Ludwigsburg, Germany | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05346393